Acquired severe aplastic anemia
DOI:
https://doi.org/10.46765/2675-374X.2025v6n1e312Keywords:
Anemia, Aplastic, Cytopenia, Bone Marrow, Hematopoietic Stem Cell TransplantationAbstract
Acquired severe aplastic anemia is a rare, life-threatening condition characterized by pancytopenia and hypocellularity of the bone marrow. It shows a bimodal age distribution, with approximately 70–80% of cases classified as idiopathic. Recent advances in hematopoietic cell transplantation, immunosuppressive therapy, biological agents, and supportive care have greatly improved survival rates, reaching a 95% cure rate. Differential diagnoses include refractory cytopenia of childhood, inherited bone marrow failure syndromes, and other blood disorders. The aim of this article was to update the Brazilian consensus previously published by the Brazilian Society of Cellular Therapy and Bone Marrow Transplantation in 2021, highlighting the latest developments in the treatment and monitoring of severe aplastic anemia patients undergoing hematopoietic cell transplantation.
References
1. Guarina A, Farruggia P, Mariani E, Saracco P, Barone A, Onofrillo D, Cesaro S, Angarano R, Barberi W, Bonanomi S, Corti P, Crescenzi B, Dell’Orso G, De Matteo A, Giagnuolo G, Iori AP, Ladogana S, Lucarelli A, Lupia M, Martire B, Mastrodicasa E, Massaccesi E, Arcuri L, Giarratana MC, Menna G, Miano M, Notarangelo LD, Palazzi G, Palmisani E, Pestarino S, Pierri F, Pillon M, Ramenghi U, Russo G, Saettini F, Timeus F, Verzegnassi F, Zecca M, Fioredda F, Dufour C. Diagnosis and management of acquired aplastic anemia in childhood. Guidelines from the Marrow Failure Study Group of the Pediatric Haemato Oncology Italian Association (AIEOP). Blood Cells Mol Dis. 2024;108:102860. https://doi.org/10.1016/j.bcmd.2024.102860 DOI: https://doi.org/10.1016/j.bcmd.2024.102860
2. Solimando AG, Palumbo C, Pragnell MV, Bittrich M, Argentiero A, Krebs M. Aplastic anemia as a roadmap for bone marrow failure: an overview and a clinical workflow. Int J Mol Sci. 2022;23(19):11765. https://doi.org/10.3390/ijms231911765 DOI: https://doi.org/10.3390/ijms231911765
3. Yoshida N. Recent advances in the diagnosis and treatment of pediatric acquired aplastic anemia. Int J Hematol. 2024;119(3):240-7. https://doi.org/10.1007/s12185-023-03564-4 DOI: https://doi.org/10.1007/s12185-023-03564-4
4. Piekarska A, Pawelec K, Szmigielska-Kapłon A, Ussowicz M. The state of the art in the treatment of severe aplastic anemia: immunotherapy and hematopoietic cell transplantation in children and adults. Front Immunol. 2024;15:1378432. https://doi.org/10.3389/fimmu.2024.1378432 DOI: https://doi.org/10.3389/fimmu.2024.1378432
5. Darrigo Junior LG, Loth G, Scheinberg P, Hallack Atta E, Bonfim C. Brazilian Consensus Meeting on Pediatric Hematopoietic Stem Cell Transplantation for Acquired Aplastic Anemia and Inherited Bone Marrow Failure Syndromes: HCT for Acquired Aplastic Anemia and Inherited Bone Marrow Failure Syndromes. J Bone Marrow Transplant Cell Ther. 2021;2(4):151. https://doi.org/10.46765/2675-374X.2021v2n4p151 DOI: https://doi.org/10.46765/2675-374X.2021v2n4p151
6. Camitta BM. Criteria for severe aplastic anaemia. Lancet. 1988;1(8580):303–4. https://doi.org/10.1016/s0140-6736(88)90388-1 DOI: https://doi.org/10.1016/S0140-6736(88)90388-1
7. Lim YJ, Arbiv OA, Kalbfleisch ME, Klaassen RJ, Fernandez C, Rayar M, Steele M, Lipton JH, Cuvelier G, Pastore YD, Silva M, Brossard J, Michon B, Abish S, Sinha R, Corriveau-Bourque C, Breakey VR, Tole S, Goodyear L, Sung L, Zlateska B, Cada M, Dror Y. Poor outcome after hematopoietic stem cell transplantation of patients with unclassified inherited bone marrow failure syndromes. Eur J Haematol. 2022;108(4):278–87. https://doi.org/10.1111/ejh.13733 DOI: https://doi.org/10.1111/ejh.13733
8. Bacigalupo A, Socié G, Schrezenmeier H, Tichelli A, Locasciulli A, Fuehrer M, Risitano AM, Dufour C, Passweg JR, Oneto R, Aljurf M, Flynn C, Mialou V, Hamladji RM, Marsh JC; Aplastic Anemia Working Party of the European Group for Blood and Marrow Transplantation (WPSAA-EBMT). Bone marrow versus
eripheral blood as the stem cell source for sibling transplants in acquired aplastic anemia: survival advantage for bone marrow in all age groups. Haematologica. 2012;97(8):1142–8. https://doi.org/10.3324/haematol.2011.054841 DOI: https://doi.org/10.3324/haematol.2011.054841
9. Bacigalupo A, Giammarco S, Sica S. Bone marrow transplantation versus immunosuppressive therapy in patients with acquired severe aplastic anemia. Int J Hematol. 2016;104(2):168–74. https://doi.org/10.1007/s12185-016-2037-8 DOI: https://doi.org/10.1007/s12185-016-2037-8
10. DeZern AE, Zahurak ML, Symons HJ, Cooke KR, Rosner GL, Gladstone DE, Huff CA, Swinnen LJ, Imus P, Borrello I, Wagner-Johnston N, Ambinder RF, Luznik L, Bolaños-Meade J, Fuchs EJ, Jones RJ, Brodsky RA. Haploidentical BMT for severe aplastic anemia with intensive GVHD prophylaxis including posttransplant cyclophosphamide. Blood Adv. 2020;4(8):1770–9. https://doi.org/10.1182/bloodadvances.2020001729 DOI: https://doi.org/10.1182/bloodadvances.2020001729
11. DeZern AE, Zahurak M, Symons HJ, Cooke KR, Huff CA, Jain T, Swinnen LJ, Imus PH, Wagner-Johnston ND, Ambinder RF, Levis M, Luznik L, Bolaños-Meade J, Fuchs EJ, Jones RJ, Brodsky RA. Alternative donor BMT with posttransplant cyclophosphamide as initial therapy for acquired severe aplastic anemia. Blood. 2023;141(25):3031–8. https://doi.org/10.1182/blood.2023020435 DOI: https://doi.org/10.1182/blood.2023020435
12. Iftikhar R, DeFilipp Z, DeZern AE, Pulsipher MA, Bejanyan N, Burroughs LM, Kharfan-Dabaja MA, Arai S, Kassim A, Nakamura R, Saldaña BJD, Aljurf M, Hamadani M, Carpenter PA, Antin JH. Allogeneic hematopoietic cell transplantation for the treatment of severe aplastic anemia: evidence-based guidelines from the American Society for Transplantation and Cellular Therapy. Transplant Cell Ther. 2024;30(12):1155–70. https://doi.org/10.1016/j.jtct.2024.09.017 DOI: https://doi.org/10.1016/j.jtct.2024.09.017
13. Marsh JC, Gupta V, Lim Z, Ho AY, Ireland RM, Hayden J, Potter V, Koh MB, Islam MS, Russell N, Marks DI, Mufti GJ, Pagliuca A. Alemtuzumab with fludarabine and cyclophosphamide reduces chronic graft versus-host disease after allogeneic stem cell transplantation for acquired aplastic anemia. Blood. 2011;118(8):2351–7. https://doi.org/10.1182/blood-2010-12-327536 DOI: https://doi.org/10.1182/blood-2010-12-327536
14. Schrezenmeier H, Passweg JR, Marsh JC, Bacigalupo A, Bredeson CN, Bullorsky E, Camitta BM, Champlin RE, Gale RP, Fuhrer M, Klein JP, Locasciulli A, Oneto R, Schattenberg AV, Socie G, Eapen M. Worse outcome and more chronic GVHD with peripheral blood progenitor cells than bone marrow in HLA-matched sibling donor transplants for young patients with severe acquired aplastic anemia. Blood. 2007;110(4):1397–400. https://doi.org/10.1182/blood-2007-03-081596 DOI: https://doi.org/10.1182/blood-2007-03-081596
15. Clé DV, Atta EH, Dias DS, Lima CB, Bonduel M, Sciuccati G, Medeiros LA, de Oliveira MM, Salvino MA, Garanito M, Saad ST, Calado RT, Scheinberg P. Repeat course of rabbit antithymocyte globulin as salvage following initial therapy with rabbit antithymocyte globulin in acquired aplastic anemia. Haematologica. 2015;100(9):e345–7. https://doi.org/10.3324/haematol.2015.123760 DOI: https://doi.org/10.3324/haematol.2015.123760
16. Darrigo LG Jr, Colturato V, de Souza MP, Loth G, Calixto R, Seber A, Zecchin VG, Esteves Daudt L, Tavares RB, Arcuri L, de Macedo AV, Vieira AK, Kuwahara C, Ribeiro L, Fernandes JF, Flowers ME, Pasquini R, Bonfim C. Allogeneic bone marrow transplants for pediatric severe aplastic anemia: real-world data comparing matched related and unrelated donors in a developing country. Retrospective study on behalf of the Pediatric Hematopoietic Stem Cell Transplant Working Group of the Brazilian Bone Marrow Transplantation Society (SBTMO) and the Brazil-Seattle Consortium (Gedeco). Pediatr Transplant. 2019;23(7):e13552. https://doi.org/10.1111/petr.13552 DOI: https://doi.org/10.1111/petr.13552
17. Kudo K, Muramatsu H, Narita A, Yoshida N, Kobayashi R, Yabe H, Endo M, Inoue M, Hara J, Kounami S, Inagaki J, Hashii Y, Kato K, Tabuchi K, Kojima S. Unrelated cord blood transplantation in aplastic anemia: is anti-thymocyte globulin indispensable for conditioning? Bone Marrow Transplant. 2017;52(12):1659–61. https://doi.org/10.1038/bmt.2017.169 DOI: https://doi.org/10.1038/bmt.2017.169
18. Arcuri LJ, Nabhan SK, Cunha R, Nichele S, Ribeiro AAF, Fernandes JF, Daudt LE, Rodrigues ALM, Arrais- Rodrigues C, Seber A, Atta EH, de Oliveira JSR, Funke VAM, Loth G, Junior LGD, Paz A, Calixto RF, Gomes AA, Araujo CES, Colturato V, Simoes BP, Hamerschlak N, Flowers ME, Pasquini R, Rocha V, Bonfim C. Impact of CD34 cell dose and conditioning regimen on outcomes after haploidentical donor hematopoietic stem cell transplantation with post-transplantation cyclophosphamide for relapsed/refractory severe aplastic anemia. Biol Blood Marrow Transplant. 2020;26(12):2311–7. https://doi.org/10.1016/j.bbmt.2020.09.007 DOI: https://doi.org/10.1016/j.bbmt.2020.09.007
19. Arcuri LJ, Nabhan SK, Loth G, Atta EH, Oliveira M, Nichele S, Araujo RC, Bonfim C. A case series of posttransplantation cyclophosphamide in unrelated donor hematopoietic cell transplantation for aplastic anemia. Biol Blood Marrow Transplant. 2020;26(9):e222–e226. https://doi.org/10.1016/j.bbmt.2020.05.023 DOI: https://doi.org/10.1016/j.bbmt.2020.05.023
20. Zhang Y, Li Y, Wu L, Zhou M, Wang C, Mo W, Chen X, Xu S, Zhou R, Wang S, Zhang Y. Mixed chimerism after allogeneic hematopoietic stem cell transplantation for severe aplastic anemia. Hematology. 2021;26(1):435–43. https://doi.org/10.1080/16078454.2021.1938422 DOI: https://doi.org/10.1080/16078454.2021.1938422
21. Drexler B, Zurbriggen F, Diesch T, Viollier R, Halter JP, Heim D, et al. Very long-term follow-up of aplastic anemia treated with immunosuppressive therapy or allogeneic hematopoietic cell transplantation. Ann Hematol. 2020;99(11):2529–38. https://doi.org/10.1007/s00277-020-04271-4 DOI: https://doi.org/10.1007/s00277-020-04271-4
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Luiz Guilherme Darrigo Junior, Gisele Loth, Virginio Climaco de Araujo Fernandes Junior, Alexandre de Albuquerque Antunes, Gabriela Gaspar Filgueiras Landi, Carmem Bonfim
This work is licensed under a Creative Commons Attribution 4.0 International License.
